Expression of LAT1 in Stage I Lung Adenocarcinoma and Its Clinical Significance

YU Bo,DING Fen-gan,MA Heng-hui,ZHANG Ru-song,HE Yan,ZHANG Xin-hua,ZHOU Xiao-jun

DOI: https://doi.org/10.3969/j.issn.1001-7399.2012.08.002

2012-01-01

Experimental Pathology

Abstract:Purpose To evaluate the prognostic value of L-type amino acid transporter 1(LAT1) expression in patients with stage I pulmonary adenocarcinoma.Methods A total of 141 consecutive patients with pathologic stage I pulmonary adenocarcinoma were retrospectively reviewed.The expression of LAT1 and Ki-67 was evaluated immunohistochemically and correlated with the prognosis of patients with complete resection of the tumor.Results The positive rates of LAT1 and Ki-67 expression were 67.4% and 56.0%,respectively.LAT1 expression was significantly correlated with disease stage(P=0.002),pleural invasion(P=0.038) recurrence and/or metastasis(P=0.003) and Ki-67 expression(P=0.037).Univariate analysis disclosed that tumor size(P=0.017),and clinical stage(P=0.000),vascular invasion(P=0.013),recurrence and/or metastasis(P=0.000),the expression of LAT(P=0.000) and Ki-67(P=0.017) in the tumor were significantly prognostic factors.The Cox regression analysis demonstrated that clinical stage(P=0.045),recurrence and/or metastasis(P=0.013) and the expression of LAT1(P=0.029) were significant independent factors to predict a poor prognosis.Conclusions The overexpression of LAT1 is a pathological factor to predict the prognosis of patients with stage I pulmonary adenocarcinoma.